HomeUNCY • NASDAQ
add
Unicycive Therapeutics Inc
Previous close
$6.00
Day range
$5.77 - $6.26
Year range
$3.72 - $11.00
Market cap
126.15M USD
Avg Volume
484.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.34M | 17.45% |
Net income | -6.01M | -46.75% |
Net profit margin | — | — |
Earnings per share | -0.33 | 34.00% |
EBITDA | -7.33M | -17.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 42.70M | 31.99% |
Total assets | 50.61M | 31.20% |
Total liabilities | 13.13M | 22.44% |
Total equity | 37.48M | — |
Shares outstanding | 21.49M | — |
Price to book | 3.33 | — |
Return on assets | -45.54% | — |
Return on capital | -67.26% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -6.01M | -46.75% |
Cash from operations | -5.96M | 35.56% |
Cash from investing | -2.00K | 91.67% |
Cash from financing | 26.33M | 16,871.97% |
Net change in cash | 20.37M | 315.92% |
Free cash flow | -4.41M | 51.79% |
About
Founded
2016
Website
Employees
23
